A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition: Malignant Melanoma, NeoplasmsInterventions: Drug: tizanidine; Drug: vemurafenibSponsor: Hoffmann-La RocheRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2013 Category: Research Source Type: clinical trials
